Andrea Fava

Nov 20, 2024 | rheumnow.com | Andrea Fava

Sleep plays a critical role in regulating inflammation and overall health. In rheumatic diseases like lupus and rheumatoid arthritis (RA), disrupted sleep is common and can exacerbate symptoms and disease progression. Experts Dr. Al Kim, Patty Katz, and Dr. Yvonne Lee emphasized the importance of addressing sleep disturbances in these conditions. The role of sleep in inflammation“Humans are proinflammatory at night, anti-inflammatory during the day, if the circadian rhythm is intact” says Dr Kim.

Sep 30, 2024 | acrjournals.onlinelibrary.wiley.com | Andrea Fava

Corresponding Author Andrea Fava Division of Rheumatology, Johns Hopkins University, Baltimore, MD, USA Corresponding author: Andrea Fava, MD, 1830 East Monument Street, Suite 7500, Baltimore, MD 21205, Telephone: 410 955 9114 – Fax 410 614 0498, Email: [email protected] Contribution: Conceptualization, Writing - original draftSearch for more papers by this author

Jun 4, 2024 | acrjournals.onlinelibrary.wiley.com | Rebecca Jacobson |Daniel Goldman |Andrea Fava |Laurence S Magder

Corresponding Author Michelle Petri MD, MPH Johns Hopkins University, Baltimore, MD Corresponding author: Michelle Petri, 1830 E Monument St. Ste. 7500, Baltimore, MD 21205, Phone: 410-382-0114, Email: [email protected] Contribution: Conceptualization, Formal analysis, Funding acquisition, ​Investigation, Methodology, Project administration, Supervision, Writing - original draft, Writing - review & editingSearch for more papers by this author

Dec 19, 2023 | lupus.bmj.com | Aaron Bao |Michelle Petri |Andrea Fava |Jun Mo Kang

Case series of anifrolumab for treatment of cutaneous lupus erythematosus and lupus-related mucocutaneous manifestations in patients with SLE Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Aug 29, 2023 | acrjournals.onlinelibrary.wiley.com | Michelle Petri |Daniel Joyce |Kristin Haag |Andrea Fava

INTRODUCTION Both systemic lupus erythematosus (SLE) itself and the use of some immunosuppressants may impact the risk of COVID-19 (1-3). In particular, corticosteroids and B cell–depleting biologics such as rituximab impair vaccine response (4-6). SLE increases the risk of severe COVID-19 (hospitalization, intensive care unit stay, or intubation) both before and after vaccination (7).